|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date21 May 1971 |
100 Clinical Results associated with Oxford Pharmaceuticals, LLC
0 Patents (Medical) associated with Oxford Pharmaceuticals, LLC
100 Deals associated with Oxford Pharmaceuticals, LLC
100 Translational Medicine associated with Oxford Pharmaceuticals, LLC